PMC - CEPI's Response to COVID-19

paper

PubMed Central(peer-reviewed)·pmc.ncbi.nlm.nih.gov/articles/PMC8063073/

Credibility Rating

4/5

High(4)

High quality. Established institution or organization with editorial oversight and accountability.

Rating inherited from publication venue: PubMed Central

This resource covers pandemic preparedness policy and institutional coordination, not AI safety. It is tangentially relevant only as a reference model for rapid-response infrastructure planning analogous to proactive AI governance frameworks.

Metadata

Importance: 18/100organizational reportnews

Summary

This Lancet Infectious Diseases article covers CEPI's $3.5 billion 5-year strategic plan launched in 2021 to reduce pandemic and epidemic risks, building on COVID-19 vaccine development successes. CEPI prioritizes next-generation vaccines, rapid-response platform technologies for unknown 'Disease X' pathogens, and vaccines against known threats like filoviruses and Lassa fever. The initiative represents a major institutional commitment to pandemic preparedness infrastructure.

Key Points

•CEPI launched a $3.5 billion, 5-year strategic plan in March 2021 focused on pandemic and epidemic preparedness beyond COVID-19.
•Key priorities include rapid-response platform technologies capable of producing vaccines against unknown 'Disease X' pathogens within 100 days.
•CEPI funded early development of mRNA and adenovirus-vectored COVID-19 vaccines, demonstrating the value of advance investment in platform technologies.
•The plan targets vaccines for known epidemic threats including filoviruses (Ebola/Marburg) and Lassa fever alongside broader preparedness.
•Improved manufacturing, equitable global delivery, and next-generation vaccine formulations are central to CEPI's forward-looking strategy.

Cited by 1 page

Page	Type	Quality
Coalition for Epidemic Preparedness Innovations	Organization	53.0

Cached Content Preview

HTTP 200Fetched Apr 7, 20269 KB

CEPI prepares for future pandemics and epidemics - PMC
 

 
 
 
 
 
 
 
 
 
 
 
 

 
 
 

 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 Skip to main content
 

 
 

 
 
 

 
 
 
 
 
 
 Official websites use .gov 
 

 A
 .gov website belongs to an official
 government organization in the United States.
 

 
 

 
 

 
 
 Secure .gov websites use HTTPS 
 

 A lock (
 
 
 Lock 
 
 Locked padlock icon
 
 
 
 ) or https:// means you've safely
 connected to the .gov website. Share sensitive
 information only on official, secure websites.
 

 
 
 
 
 
 

 

 
 
 
 

 
 

 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 

 
 Search PMC Full-Text Archive 
 
 
 
 
 Search in PMC 
 
 
 
 
 
 
 
 
 Journal List
 
 
 

 
 
 
 User Guide
 
 
 

 
 
 
 
 

 

 
 

 
 

 

 

 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 

 
 
 
 

 
 
 

 
 
 
 
 
 
 

 
 
 
 
 
 

 
 
 
 
 
 

 
 
 PERMALINK

 
 
 
 
 Copy 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
 the contents by NLM or the National Institutes of Health.

 Learn more:
 PMC Disclaimer 
 |
 
 PMC Copyright Notice
 
 
 
 
 
 
 

 
 
 Lancet Infect Dis . 2021 Apr 23;21(5):608. doi: 10.1016/S1473-3099(21)00216-4 
 
 
 CEPI prepares for future pandemics and epidemics

 
 Udani Samarasekera 
 Udani Samarasekera 

 Find articles by Udani Samarasekera 
 
 
 
 
 Article notes 

 Copyright and License information 

 
 
 Issue date 2021 May.

 
 
 © 2021 Elsevier Ltd. All rights reserved. 
 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

 PMC Copyright notice 
 
 
 PMCID: PMC8063073  PMID: 33894843 
 
 
 On March 10, 2021, the Coalition for Epidemic Preparedness Innovations launched a US$3·5 billion plan to reduce the risk of future pandemics and epidemics. Udani Samarasekera reports.

 The Coalition for Epidemic Preparedness Innovations ( CEPI ) has always been forward-looking. Launched in 2017, CEPI is a global partnership between public and private organisations that aims to develop vaccines to tackle future epidemics. Since its inception, it has facilitated and funded the development of vaccine candidates against known threats, as well developing rapid-response platform technolog

... (truncated, 9 KB total)

Resource ID: 463164d2b60f980e | Stable ID: sid_Oq1eA0Eo1w